156 results
Page 2 of 8
8-K
5ha 8437ln
28 Apr 22
Conference Call Script
8:00am
8-K
EX-99.1
8vfhdwlg1xtjx2t
20 Apr 22
Ampio Provides Regulatory Update
9:43pm
8-K
EX-99.1
78p9q
29 Mar 22
Ampio Pharmaceuticals Reports Fourth-Quarter and Full-Year 2021 Financial Results and Operational Highlights
4:17pm
8-K
EX-99.1
7359nyez
2 Mar 22
Complete analysis of AP-013 data show Ampion reduced pain with statistical significance
4:38pm
8-K
EX-99.2
9j3wb za4
2 Mar 22
Complete analysis of AP-013 data show Ampion reduced pain with statistical significance
4:38pm
8-K
EX-99.1
6v5u0ej6b
16 Dec 21
Regulation FD Disclosure
4:01pm
8-K
EX-10.2
uhygk4v72r i4potrt
15 Dec 21
Entry into a Material Definitive Agreement
12:00am
424B5
pqv8fn
14 Dec 21
Prospectus supplement for primary offering
5:06pm
8-K
EX-99.1
fhva3p721v9n1775
15 Sep 21
Other Events
9:25am
8-K
EX-99.1
qf8fqt z58
5 May 21
Results of Operations and Financial Condition
4:05pm
8-K
EX-99.1
yzo3doi6tr12
3 Mar 21
Ampio Pharmaceuticals, Inc. Reports Fourth Quarter 2020 Financial Results and Provides Business Update
4:05pm
8-K
EX-99.1
ntioukdmlf9r0c6p
5 Nov 20
Ampio Pharmaceuticals, Inc. Provides Business Update and Reports Third Quarter 2020 Financial Results
4:01pm
424B5
o6r5dzww8ek89phra
6 May 20
Prospectus supplement for primary offering
5:16pm